1. Home
  2. GRBK vs ARQT Comparison

GRBK vs ARQT Comparison

Compare GRBK & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Green Brick Partners Inc.

GRBK

Green Brick Partners Inc.

N/A

Current Price

$73.97

Market Cap

3.2B

ML Signal

N/A

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

N/A

Current Price

$26.74

Market Cap

3.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GRBK
ARQT
Founded
N/A
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.3B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
GRBK
ARQT
Price
$73.97
$26.74
Analyst Decision
Buy
Strong Buy
Analyst Count
2
7
Target Price
$71.00
$24.83
AVG Volume (30 Days)
225.1K
1.6M
Earning Date
02-25-2026
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
7.63
N/A
Revenue
$2,113,173,000.00
$317,929,000.00
Revenue This Year
N/A
$85.83
Revenue Next Year
$3.35
$30.72
P/E Ratio
$9.57
N/A
Revenue Growth
6.62
129.21
52 Week Low
$50.57
$11.13
52 Week High
$77.93
$31.77

Technical Indicators

Market Signals
Indicator
GRBK
ARQT
Relative Strength Index (RSI) 64.01 43.38
Support Level $69.31 $25.12
Resistance Level $75.00 $26.93
Average True Range (ATR) 2.42 1.44
MACD 0.56 -0.28
Stochastic Oscillator 84.69 27.53

Price Performance

Historical Comparison
GRBK
ARQT

About GRBK Green Brick Partners Inc.

Green Brick Partners Inc is a homebuilding and land development company. It acquires and develops land, as well as provides land and construction financing to its controlled builders. The company has three reportable segments: builder operations central, builder operations southeast, and land development. The majority of the company's revenue is generated from the builder operations central segment which is entirely the operations of builders in Texas. The company is engaged in various aspects of the homebuilding process, including land acquisition and development, entitlements, design, construction, marketing, sales, and brand image creation. In addition to homebuilding, the company provides home financing services, such as mortgage and title.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

Share on Social Networks: